Connexin 26 (GJB2) mutations in two Swedish patients with atypical Vohwinkel (mutilating keratoderma plus deafness) and KID syndrome both extensively treated with acitretin

Acta Dermato-Venereologica

Volumn 86, Issue 6, 2006, Pages 503-508

  Bondeson, Marie Louise ^a,b   Nyström, Anna Maja ^a   Gunnarsson, Ulrika ^a   Vahlquist, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Acitretin; Cancer; Cx26, mutation; Deafness; Genodermatosis

Indexed keywords

CONNEXIN 26; ETRETIN; RETINOID;

ADULT; AGED; ANAMNESIS; ARTICLE; ATYPICAL VOHWINKEL; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DNA DETERMINATION; ECTODERMAL DYSPLASIA; FEMALE; GENE MUTATION; GENOTYPE; HEARING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATITIS ICHTHYOSIS DEAFNESS; KERATODERMA; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; SKIN DEFECT;

ACITRETIN; ADMINISTRATION, ORAL; ADULT; AGED; CONNEXINS; DEAFNESS; FEMALE; HUMANS; ICHTHYOSIS; KERATITIS; KERATODERMA, PALMOPLANTAR; KERATOLYTIC AGENTS; MALE; MUTATION; SYNDROME;

EID: 33845683026     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0164     Document Type: Article

References (29)

1. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Guldenagel M, et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383: 725-737.
2. Peris K, Salvati EF, Torlone G, Chimenti S. Keratoderma hereditarium mutilans (Vohwinkel's syndrome) associated with congential deaf-mutism. Br J Dermatol 1995; 132: 617-620.
3. Solis RR, Diven DG, Trizna Z. Vohwinkel's syndrome in three generations. J Am Acad Dermatol 2001; 44: 376-378.
4. Caceres-Rios H, Tamayo-Sanchez L, Duran-McKinster C, de la Luz Orozco M, Ruiz-Maldonado R. Keratitis, ichthyosis, and deafness (KID syndrome): review of the literature and proposal of a new terminology. Pediatr Dermatol 1996; 13: 105-113.
5. Chang Sing Pang AF, Oranje AP, Vuzevki VD, Stoltz E. Successful treatment of keratoderma hereditaria mutilans with an aromatic retinoid. Arch Dermatol 1981; 117: 225-228.
6. Camisa C, Rossana C. Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome). Treatment with orally administered isotretinoin. Arch Dermatol 1984; 120: 1323-1328.
7. Wereide K. Mutilating palmoplantar keratoderma successfully treated with etretinate. Acta Derm Venereol 1984; 64: 566-569.
8. Rivers JK, Duke EE, Justus DW. Etretinate: management of keratoma hereditaria mutilans in four family members. J Am Acad Dermatol 1985; 13: 43-49.
9. Bygum A, Betz RC, Kragballe K, Steiniche T, Peeters N, Wuyts W, Nöthen MM. KID syndrome: report of a Scandinavian patient with connexin-26 gene mutation. Acta Derm Venerol 2005; 85: 152-155.
10. Gibbs RC, Frank SB. Keratoma hereditaria mutilans (Vohwinkel): differentiating features of conditions with constriction of digits. Arch Dermatol 1966; 94: 619-625.
11. Maestrini E, Korge BP, Ocaña-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999; 8: 1237-1243.
12. Kelsell DP, Wilgoss AL, Richard G, Stevens HP, Munro CS, Leigh IM. Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. Eur J Hum Genet 2000; 8: 141-144.
13. Snoeckx, R, Hassan DM, Kamal NM, van den Bogaert K, van Camp G. Mutation analysis of the GJB2 (connexin 26) gene in Egypt. Hum Mutat 2005; 26: 60-61.
14. Uyguner O, Tukel T, Baykal C, Eris H, Emiroglu M, Hafiz G, et al. The novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar kerato derma in a Turkish family. Clin Genet. 2002; 62: 306-309.
15. Korge BP, Ishida-Yamamoto A, Pünter C, Dopping-Hepenstal PJC, Iizuka H, Stephenson A, et al. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997; 109: 604-610.
16. Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, et al. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996; 13: 70-77.
17. Heathcote K, Syrris P, Carter ND, Patton, MA. A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet 2000; 37: 50-51.
18. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynänen M, et al. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet 2002; 70: 1341-1348.
19. van Geel M, van Steensel MAM, Küster W, Hennies HC, Happle R, Steijlen PM, et al. HID and KID syndromes are associated with the same connexin 26 mutation. Br J Dermatol 2002; 146: 938-942.
20. van Steensel MA, van Geel M, Nahuys M, Smitt JH, Steijlen PM. A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome. J Invest Dermatol 2002; 118: 724-727.
21. Alvarez A, del Castillo I, Pera A, Villamar M, Moreno-Pelayo MA, Moreno F, et al. De novo mutation in the gene encoding connexin-26 (GJB2) in a sproadic case of keratitis-ichtyosis-deafness (KID) syndrome. Am J Med Genet 2003; 117A: 89-91.
22. Yotsumoto S, Hashiguchi T, Chen X Ohtaki N, Tomitaka A, Akamatsu H, et al. Novel mutations in GJB2 encoding connexin-26 in Japanese patients with keratitis-ichtyosis-deafness syndrome. Br J Dermatol 2003; 148: 649-653.
23. Brown CW, Levy ML, Flaitz CM, Reid BS, Manolidis S, Hebert AA, et al. A novel GJB2 (connexin 26) mutation, F142L, in a patient with unusual mucocutaneous findings and deafness. J Invest Dermatol 2003; 121: 1221-1223.
24. Richard G. Connexin gene pathology. Clin Exp Dermatol 2003; 28: 397-409.
25. Jan AY, Amin S, Ratajczak P, Richard G, Sybert VP. Genetic heterogeneity of KID syndrome: identification of a Cx30 Gene (GJB6) mutation in a patient with KID syndrome and congenital atricia. J Invest Dermatol 2004; 122: 1108-1113.
26. Rouan F, White TW, Brown N, Taylor AM, Lucke TW, Paul DL, et al. Trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci. 2001; 114: 2105-2113.
27. Bakirtzis G, Choudhry R, Aasen T, Shore L, Brown K, Bryson S, et al. Targeted epidermal expression of mutant connexion 26 (D66H) mimics true Vohwinkel syndrome and provides a model for the pathogenesis of dominant connexin disorders. Hum Mol Genet 2003; 12: 1737-1744.
28. del Castillo I, Villamar M, Moreno-Pelyao MA, del Castillo FJ, Alvarez A, Telleria D, et al. A deletion involving the connexin 30 gene in nonsyndromic hearing impairment. N Engl J Med 2002; 24: 243-249.
29. Richard G, Brown N, Ishida-Yamamoto A, Krol A. Expanding the phenotypic spectrum of Cx26 disorders: Bart-Pumphrey Syndrome is caused by a novel missense mutation in GJB2. J Invest Dermatol 2004; 123: 856-863.